FIELD: medicine. SUBSTANCE: peptides of the formula I: R-Arg-X-Y-Z-R1 where R - hydrogen, acetyl, formyl; X - proline (Pro); Y - L-Ala, L-Asp, L-Val; Z - L-Val, L-Ala; R1 - H, OH, NH2, NH(CH3), NHCH(CH3)2, methods of their synthesis by solid-phase procedure using cellulose, polyvinyl alcohol, polymethylmethacrylate, polystyrene and polystyrenedivinylbenzene as a backing for polymer or copolymer, or in the solution by step-stage or block amino acid or peptide fragment connection. Composition contains at least one peptide of the formula I as an active substance at the effective amount. EFFECT: improved method of synthesis. 10 cl, 8 dwg, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
PEPTIDES AND COMPOSITION ON THEIR BASE CAPABLE TO REGULATE IMMUNE FUNCTION IN MAMMALIAN | 1990 |
|
RU2036930C1 |
PEPTIDE WITH IMMUNO-SIMULATING ACTIVITY AND PREPARATION BASED ON SUCH PEPTIDE | 1997 |
|
RU2142958C1 |
METHOD OF PREPARING CYCLIC PEPTIDES | 0 |
|
SU849998A3 |
DECAPEPTIDE SHOWING ANTITUMOR ACTIVITY | 1993 |
|
RU2084458C1 |
METHOD OF PREPARING PEPTIDES SHOWING TISSUE-SPECIFIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2161501C1 |
OPIOID PEPTIDES AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2146681C1 |
PEPTIDE DERIVATIVES AND METHOD OF THEIR PRODUCTION | 1992 |
|
RU2087480C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1994 |
|
RU2100369C1 |
METHOD OF OBTAINING PEPTIDES | 0 |
|
SU1575944A3 |
DERIVATIVES OF BORON-CONTAINING PEPTIDES | 1991 |
|
RU2017749C1 |
Authors
Dates
1996-05-27—Published
1989-05-08—Filed